miRecule
Gaithersburg, Maryland, United States · Biotechnology, Genetics, Health Care
miRecule, Inc. is a biotechnology company focused on developing next-generation RNA therapeutics for rare genetic diseases. The company aims to enable precise genetic-level interventions through innovative therapies. Their proprietary NAVIgGator™ platform supports the design of precision RNA medicines.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- Gaithersburg, Maryland, United States
- Employees
- 2
- Industries
- Biotechnology, Genetics, Health Care
- Status
- Private
- Website
- mirecule.com
- Company page
Recent activity at miRecule
Employee benefit plans
miRecule files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
About miRecule: questions and answers
What does miRecule do?
miRecule, Inc. is a biotechnology company focused on developing next-generation RNA therapeutics for rare genetic diseases. The company aims to enable precise genetic-level interventions through innovative therapies. Their proprietary NAVIgGator™ platform supports the design of precision RNA medicines.
Where is miRecule headquartered?
miRecule is headquartered in Gaithersburg, Maryland, United States.
How many employees does miRecule have?
miRecule has about 2 employees.
What is the latest news on miRecule?
On Jul 31, 2026, miRecule Partners with EMS Group Company Rio Biopharma to Enhance RNA Therapeutics Delivery.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy